» Articles » PMID: 20038813

Stat3-dependent Acute Rantes Production in Vascular Smooth Muscle Cells Modulates Inflammation Following Arterial Injury in Mice

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2009 Dec 30
PMID 20038813
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammation is a key component of arterial injury, with VSMC proliferation and neointimal formation serving as the final outcomes of this process. However, the acute events transpiring immediately after arterial injury that establish the blueprint for this inflammatory program are largely unknown. We therefore studied these events in mice and found that immediately following arterial injury, medial VSMCs upregulated Rantes in an acute manner dependent on Stat3 and NF-kappaB (p65 subunit). This led to early T cell and macrophage recruitment, processes also under the regulation of the cyclin-dependent kinase inhibitor p21Cip1. Unique to VSMCs, Rantes production was initiated by Tnf-alpha, but not by Il-6/gp130. This Rantes production was dependent on the binding of a p65/Stat3 complex to NF-kappaB-binding sites within the Rantes promoter, with shRNA knockdown of either Stat3 or p65 markedly attenuating Rantes production. In vivo, acute NF-kappaB and Stat3 activation in medial VSMCs was identified, with acute Rantes production after injury substantially reduced in Tnfa-/- mice compared with controls. Finally, we generated mice with SMC-specific conditional Stat3 deficiency and confirmed the Stat3 dependence of acute Rantes production by VSMCs. Together, these observations unify inflammatory events after vascular injury, demonstrating that VSMCs orchestrate the arterial inflammatory response program via acute Rantes production and subsequent inflammatory cell recruitment.

Citing Articles

Mast cell activation and degranulation in acute artery injury: A target for post-operative therapy.

Harper R, Fang F, San H, Negro A, St Hilaire C, Yang D FASEB J. 2023; 37(7):e23029.

PMID: 37310585 PMC: 11095138. DOI: 10.1096/fj.202201745RR.


MYC-mediated silencing of miR-181a-5p promotes pathogenic Th17 responses by modulating AKT3-FOXO3 signaling.

Chen S, Ma B, Li X, Zhang K, Wei Y, Du B iScience. 2022; 25(10):105176.

PMID: 36248732 PMC: 9557906. DOI: 10.1016/j.isci.2022.105176.


Protective Effects of Silibinin on -induced Gastritis: NF-κB and STAT3 as Potential Targets.

Cho K, Lee H, Piao J, Kim S, Na H, Surh Y J Cancer Prev. 2021; 26(2):118-127.

PMID: 34258250 PMC: 8249208. DOI: 10.15430/JCP.2021.26.2.118.


DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension.

Yan Y, He Y, Jiang X, Wang Y, Chen J, Zhao J Sci Adv. 2020; 6(50).

PMID: 33298433 PMC: 7725449. DOI: 10.1126/sciadv.aba2470.


WD Repeat Domain 1 Deficiency Inhibits Neointima Formation in Mice Carotid Artery by Modulation of Smooth Muscle Cell Migration and Proliferation.

Hu J, Pi S, Xiong M, Liu Z, Huang X, An R Mol Cells. 2020; 43(8):749-762.

PMID: 32868491 PMC: 7468582. DOI: 10.14348/molcells.2020.0085.


References
1.
Kuziel W, Dawson T, Quinones M, Garavito E, Chenaux G, Ahuja S . CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis. 2003; 167(1):25-32. DOI: 10.1016/s0021-9150(02)00382-9. View

2.
Coqueret O, Gascan H . Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J Biol Chem. 2000; 275(25):18794-800. DOI: 10.1074/jbc.M001601200. View

3.
Braunersreuther V, Steffens S, Arnaud C, Pelli G, Burger F, Proudfoot A . A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Arterioscler Thromb Vasc Biol. 2008; 28(6):1090-6. DOI: 10.1161/ATVBAHA.108.165423. View

4.
Schwarz J, Langwieser N, Langwieser N, Bek M, Seidl S, Eckstein H . Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1. Circ Res. 2008; 104(2):189-200. DOI: 10.1161/CIRCRESAHA.108.182683. View

5.
Lee A, Hong J, Seo Y . Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J. 2000; 350 Pt 1:131-8. PMC: 1221234. View